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ARTICLE
RIG-I-like receptors direct inflammatory
macrophage polarization against West
Nile virus infection
Amy E.L. Stone1,2, Richard Green1, Courtney Wilkins1, Emily A. Hemann 1 & Michael Gale Jr. 1
RIG-I-Like Receptors (RLRs) RIG-I, MDA5, and LGP2, are vital pathogen recognition receptors
in the defense against RNA viruses. West Nile Virus (WNV) infections continue to grow in
the US. Here, we use a systems biology approach to define the contributions of each RLR in
the innate immune response to WNV. Genome-wide RNAseq and bioinformatics analyses of
macrophages from mice lacking either RLR reveal that the RLRs drive distinct immune gene
activation and response polarization to mediate an M1/inflammatory signature while sup-
pressing the M2/wound healing phenotype. While LGP2 functions to modulate inflammatory
signaling, RIG-I and MDA5 together are essential for M1 macrophage polarization in vivo and
the control of WNV infection through potential downstream control of ATF4 and SMAD4 to
regulate target gene expression for cell polarization. These analyses reveal the RLR-driven
signature of macrophage polarization, innate immune protection, and immune programming
against WNV infection.
https://doi.org/10.1038/s41467-019-11250-5 OPEN
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Sciences, Touro University Nevada, Henderson, NV 89014, USA. Correspondence and requests for materials should be addressed to M.G.Jr. (email: mgale@uw.edu)
NATURE COMMUNICATIONS |         (2019) 10:3649 | https://doi.org/10.1038/s41467-019-11250-5 |www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
RIG-I-like receptors (RLRs) are cytosolic pathogen recognitionreceptors (PRRs) that detect RNA virus infection. The RLRfamily consists of RIG-I, MDA5, and LGP2. RIG-I and
MDA5 are signaling effectors1 while LGP2 is a regulator of RLR
signaling2,3. During virus infection, RLRs bind to viral RNA and
activate the adaptor protein, MAVS leading to the induction of
inflammatory and antiviral genes, including interferons (IFN) and
IFN-stimulated genes (ISGs). RLR signaling also directs the reg-
ulation of additional transcription factors to impart innate immune
activation and immune polarization, but the RLR- transcriptome
and responsive factors that mediate these processes are not defined.
RLRs are critical for immune defense against a range of RNA
viruses4 including flaviviruses that are recognized through both
RIG-I and MDA55, yet the specific contributions of each receptor to
the innate immune response are unclear. West Nile Virus (WNV) is
a neurotropic flavivirus that is the most common arboviral infection
and a major cause of viral encephalitis in the USA6. With no
treatments or vaccines available, WNV represents a public health
concern7. Innate immunity is essential for controlling WNV
wherein RLR signaling induces innate immune defenses that restrict
and control infection and viral neuroinvasion from peripheral sites8.
RLR signaling serves to regulate the character of the acquired
immune response against WNV8 and is essential for systemic
control of infection and pathogenesis9. Importantly, macrophages
are pivotal for control of WNV infection in most tissues. They are a
major tropic cell of WNV and serve to control WNV neuroinva-
sion10. However, the role of RLRs in programming the macrophage
response to WNV infection is unknown.
In mouse models of WNV infection, subcutaneous virus challenge
first infects lymphoid resident macrophages followed by infection of
splenic macrophages11 before migrating to the CNS12,13. Macro-
phages are functionally categorized into two broad groups: proin-
flammatory function (M1) or wound healing anti-inflammatory
actions (M2), with each linked with specific functions14. During virus
infection, externally-derived signals such as cytokine signaling or
pathogen recognition drive macrophage polarization to M1 or M2
phenotype. M1s recruit immune cells to the site of infection while
M2s resolve the inflammatory response14. M1 macrophages arise as
part of the immune response to infection mediated by the tran-
scription factors NF-κB, IRF3, and STAT115. M2 macrophages take
on tissue repair and resolution of inflammation through activation of
the transcription factors STAT3 and STAT615. The induction of one
phenotype commits the macrophage to a single polarization until the
microenvironment changes14. However, the role of the RLRs in this
process are not known.
Here we apply a systems biology approach employing tran-
scriptomic and functional analyses of primary macrophages to
assess RLR regulation during WNV infection. Our study shows
that each RLR plays a unique role in protection against WNV. We
define the RLR transcriptome and reveal that RLR signaling drives
an M1 phenotype to control WNV infection. Our results show
that RLR signaling links to ATF4 and SMAD4 transcription fac-
tors and regulates M1 and M2 gene expression that direct mac-
rophage polarization to impart innate immunity against WNV.
Results
RIG-I-like receptors control West Nile virus infection. Inde-
pendent studies have revealed roles for RIG-I, MDA5, and LGP2
in the control of WNV infection16. We directly compared the
susceptibility of mouse cohorts lacking the RLRs alone or in
combination. During WNV infection, mice lacking each RLR had
distinct infection outcome (Fig. 1a). Comparative analysis shows
that WT mice are overall less susceptible (71.8% survival) than
any RLR knockout (range 50–0% survival). Loss of both RIG-I
and MDA5 phenocopied mice lacking MAVS, as all mice
succumbed to infection within 8 days after viral challenge. While
mice lacking RIG-I or MDA5 had similar increased WNV sus-
ceptibility over WT, LGP2−/− mice succumbed to WNV at a
higher rate, likely reflecting specific functions in effector T-cell
expansion17. These observations indicate that each RLR plays a
unique role in directing the outcome of WNV infection in vivo
where one RLR does not compensate for lack of another.
We utilized our cohort of RLR knockout mice to assess RLR-
dependent responses in WNV infection of primary bone marrow-
derived macrophages (BMMs). BMMs were derived from WT,
MDA5−/−, LGP2−/−, RIG-I−/−xMDA5−/− DKO (DKO), or
RIG-I−/− mice. These BMMs expressed equivalent levels of each
RLR, except the targeted knockout (Fig. 1b). As Toll-like receptor
(TLR)3 and 7 have been implicated as PRRs of WNV16, we
determined the levels of these TLR to be comparable in WT and
DKO BMMs (Fig. 1c) and functionally active (Supplementary Fig. 1).
WT and DKO BMMs induced similar amounts of IFNβ in response
to TLR stimulation. Notably, when infected with WNV, WT cells,
but not DKO cells, induced a high level of IFNβ expression despite
the presence of functional TLR3 and TLR7 in the DKO BMMs
(Supplementary Fig. 1). We found that each BMM genotype
supported productive infection but WNV replicated to the highest
levels in DKO cells (Fig. 1d). These results demonstrate that RIG-I
and MDA5, not TLR3/7, serve as the primary PRRs to direct innate
immunity against WNV infection in macrophages.
RLR-dependent transcriptional programs in macrophages. We
performed RNAseq on WT and RLR-deficient BMMs infected with
the WNV-TX02 infectious clone18 and analyzed the results through
an immuno-informatics pipeline (Fig. 2a). We compared global
gene expression analysis of mock to WNV infection of each sepa-
rate genotype to identify differentially expressed (DE) genes (Sup-
plementary Data 1). The BMMs had similar numbers of DE genes
except DKO samples, which had significantly fewer DE genes
despite having a similar number of overall reads (Fig. 2b). DKO
BMMs had the highest percent of viral reads (Supplementary
Fig. 2A), with viral genome sequence reads distributed uniformly
across the WNV genome (Supplementary Fig. 2B). As the back-
grounds of the mice varied, we compared the B6 mock samples to
the RIG-I+/+ mock samples and found that the WT samples were
highly similar (Supplementary Fig. 3, r2 = 0.975). We used the B6
WT as our representative WT in future analyses.
Figure 2c shows a heatmap of the DE genes (p > 0.01, 2-fold
minimum change) of each genotype compared against WT DE
genes. Genes were grouped based on similar expression patterns to
reveal modules of functional categories. We defined five major gene
modules, with innate immunity and immune-regulatory genes
dominating the response modules. These analyses also revealed that
WNV infection suppresses extracellular matrix (ECM) organization
genes, which is characteristic of activated macrophages increasing
chemotaxis and cell movement19. Comparing our DE genes to the
Matrisome20, we found that WNV-infected BMMs were actively
changing their ECM genes in an RLR-dependent manner (Supple-
mentary Fig. 4). Global gene expression examination revealed striking
differences between the single knockout cohorts and the DKO cells.
Most DE genes identified in the WT response failed to change in the
DKO BMMs during WNV infection and some genes had opposite
directionality. These results show that DKO cells fail to initiate a
specific transcriptional response against WNV infection despite
having functional TLRs. The DE deficits in DKO cells thus represent
RLR-dependent genes that contribute to activation of macrophages
for viral control of WNV.
Linking the DE genes to immunity among the genotypes, we
found the GO classifications of immune response (Supplementary
Fig. 5A, Supplementary Data 2) or innate immune response
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(Supplementary Fig. 5B, Supplementary Data 3), severely dysregu-
lated in DKO cells. Examining the IFN response to WNV, the DE
genes were divided into ISGs (as defined by the WT BMM response
to IFNβ treatment; Supplementary Data 4) and non-ISGs (Supple-
mentary Fig. 5C/Supplementary Data 5, and Supplementary Fig. 5D/
Supplementary Data 6, respectively). WNV infection induced a
strong ISG response but this response was largely absent in DKO
cells. ISGs segregate into functional categories consistent with
macrophage activation (Supplementary Fig. 5C). By subtracting ISGs
(Supplementary Data 4) from the DE gene set, we identified WNV-
induced non-ISG responses occurring in all genotypes except the
DKO, thus defining the virus-induced macrophage response to
infection beyond the canonical IFN-stimulated response.
RLR-dependent virus-induced genes. To dissect the roles RIG-I
and MDA5 play in response to WNV, we filtered the overall gene list
to identify RLR-dependent genes. Starting from the WT DE list we
removed any DE gene that was also found in the DKO cells, leaving
only the genes whose differentially expression relies on the presence
of RIG-I and MDA5 during WNV infection (Fig. 3a). Using the
subsequent heatmap of those genes, we found that many of the RLR-
dependent genes are present in the single RLR KO cells, suggesting
that compensation between the RLR family members can occur at
the gene expression level (Fig. 3b, Supplementary Data 7). While the
DKO cells were deficient in regulating ISGs (Supplementary Fig. 6A),
they also fail to regulate novel virus-induced non-ISGs found in the
WT response (Supplementary Fig. 6B). These analyses suggest that
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Fig. 1 RIG-I-like Receptors (RLRs) impart control of WNV infection. a Mice were infected with 100 pfu WNV in the footpad and monitored for survival for
21 days. Percent survival is shown. Significance stars for each line compared to the Wild-type (WT) line (combined C57Bl/6 [n= 24] and RIG-I+/+WTs
[n= 12] 36 total mice) are shown. RIG-I−/−, MDA5−/−, and LGP2−/− n= 15 mice each; MAVS−/− n= 7 mice; RIG-I/MDA5 DKO n= 10 mice. b BMMs
from each genotype were infected or mock infected with WNV at MOI 1 and harvested at 24 h post-infection. Cell lysates were assayed for the presence of
RLR proteins, WNV NS3 protein, and actin by western blot. c WT (blue) or DKO (red) BMMs were stained for flow cytometry for TLR proteins or
macrophage markers. Histograms for each assayed marker are shown. d BMMs from each genotype were infected for 24 or 48 h with WNV at MOI 2.5.
The supernatants were harvested and assayed for viral load by focus forming unit (FFU) assay. Bars represent the mean viral load ± SEM from n= 3
independent sets of supernatants assayed for virus in triplicate. Panels b and c show representative data from n= 3 independent experiments. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001 (log-rank;Mantel-Cox for survival curves and Ordinary one-way ANOVA with Holm-Sidak’s multiple-comparisons
post-test for ffu analysis). Source data are provided as a Source Data file
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Fig. 2 RLRs dictate the transcriptome response to WNV infection. a Experimental design. BMMs were infected with WNV at MOI 2.5 for 24 or 48 h when
RNA and supernatants were harvested for analysis. RNA was submitted to RNA sequencing and analyzed through an Immuno-informatics pipeline. Gene
expression was determined by comparing the number of reads in the infected condition compared to that genotype’s mock condition. b Bar graph
representing the total number of differentially expressed genes by genotype and time point. Induced genes are shown in red as positive numbers while
suppressed genes are shown in blue as negative numbers. A single value is shown for each genotype and time point. c) Heatmap of global gene expression.
Genes significantly changed in the WT response compared to the WT mock are shown on the heatmap as horizontal rows. The columns are each genotype
at the noted time points. Genes that had more mapped reads in the infected condition are shown in red while genes that had fewer mapped reads in the
infected condition are shown in blue. On the right, genes with similar expression are grouped into blocks and assigned functional terms. n= 3 independent
infections, RNA preparations, and sequencing results. Source data are provided as a Source Data file
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the RLRs regulate additional intracellular response pathways beyond
IFN to contribute directly to the depth and breadth of the antiviral
response. The overlap between RIG-I, MDA5, and RIG-I-&-MDA5-
(RLR)-dependent genes among each BMM genotype are shown by
Venn diagram (Fig. 3c).
Pathway analysis on the total DE genes from each genotype
defined the functional outcomes of RLR-dependent genes (Fig. 3d).
WT BMMs induced innate antiviral immunity and inflammatory
signaling pathways, and suppressed macrophage chemotaxis and
immune regulation pathways, as found in the M1 phenotype15.
RLR-dependent module expression was altered in the DKO cells,
marked by loss of inflammatory signaling modules, more typical
patterns of M2 polarization21 but with enhancement of inflamma-
tory and apoptotic signaling. These data suggest that RLR-
dependent genes contribute to macrophage polarization.
Transcriptional macrophage polarization requires the RLRs.
To understand how the RLR-dependent transcriptome con-
tributed to macrophage function, we focused our analysis on six
functional categories of genes: ISGs, Innate Immune genes, Th1
genes, Th2 genes, M1 genes, and M2 genes. Innate Immune, Th1,
and Th2 genes were identified through GO Biological Process
lists. M1 and M2 were defined as in a recent macrophage
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polarization meta-analysis22. ISGs were defined by us as described
in Supplementary Fig. 5C. The proportion of genes that were
significantly induced (or, separately, suppressed) in the WT
response for each category out of the total possible genes in that
category was determined. The resulting proportions were graphed
on a radar plot (Fig. 4a). We found that infected WT cells were
dominated by an M1 response while displaying minimal M2
polarization (Fig. 4a, black lines). WT cells also displayed a
balanced Th1 and Th2 transcriptional response, while ISG
induction and innate immune gene induction were comparably
smaller components of the WT BMM response to WNV infec-
tion. WT BMMs actively suppress M2 transcriptional responses.
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Together this analysis shows that WNV infection of WT BMMs
induces a M1/proinflammatory transcriptome while suppressing
the M2/wound healing macrophage phenotype.
To determine RLR-dependence for directing macrophage
polarization in WNV infection, we conducted gene expression
proportion analysis on the DKO DE genes and overlaid the
proportions on the WT radar plots (Fig. 4a, red lines). These
analyses show that loss of RIG-I and MDA5 results in loss of
virus-induced macrophage polarization. Heatmaps showing the
fold change of the M1, M2, Th1, and Th2 genes used in these
analyses as well as the overlap of genes among the categories are
shown in Supplementary Fig. 7. Representative M1 and M2 genes
were verified by RT-PCR following WNV infection in freshly
generated BMMs (Fig. 4b). Remarkably, differential gene
expression of each functional category is largely absent in the
DKO cells (Supplementary Datas 8–11). Taken together, these
data reveal that macrophage transcriptional polarization pro-
gramming depends on RIG-I and MDA5 during WNV infection.
Macrophages can be polarized in vitro using pathogen and
host-derived signals that bypass RLR signaling. To determine if
RLR-deficiency disrupted macrophage polarization through
classic stimuli, we treated WT and DKO BMMs with IFNγ/LPS
or IL-4/IL-13 to induce an M1 or M2 phenotype, respectively,
and assessed downstream macrophage characteristics. Assess-
ment of cell surface macrophage markers, gene expression, and
macrophage functions of nitrite production and arginase activity
(Fig. 4c–g), showed that in response to these classical macrophage
polarization stimuli, both DKO BMMs and WT BMMs were
equivalently polarized to M1 or M2 outcome, respectively. Thus,
RLR-deficient BMMs are capable of polarization when activated
through classical pathways bypassing RLR signaling but WNV-
induced polarization requires the RLRs.
RLR-specific gene signature and function. The contribution of
individual RLRs to drive gene expression signatures within
macrophages during WNV infection was examined, allowing us
to identify RLR-specific gene response networks (Supplementary
Data 7). We identified genes whose expression is regulated by
multiple RLRs, as assessed by the Venn diagram (Fig. 5a). GO
analyses identified the functional categories of the RLR-
dependent genes that were variably induced and suppressed in
expression in a manner dependent on the different RLRs
(Fig. 5b). In particular, beyond innate immune genes, we found
that RIG-I and MDA5 are essential for expression of gene net-
works involved in cell metabolism, redox pathways, nucleotide
biosynthesis, and translation, all known process that impact
macrophage polarization23. Overall these results reveal a pattern
of gene expression consistent with the progressive distribution of
WNV PAMP sensing and signaling by RLRs5.
We examined the six functional gene categories defined in
figure 4 and found that the polarization of BMMs to M1 gene
expression with M2 gene suppression was preserved in the
individual lines lacking either RIG-I, MDA5, or LGP2 (Fig. 5c).
Differences in the magnitude of DE gene regulation in each
category were observed, reflecting unique patterns of expression
directed by each RLR. When compared with the Fig. 4 data, these
results reveal that while any single RLR contributes to the
macrophage polarization programming during WNV infection, it
is the combination of RIG-I and MDA5 that direct the
macrophage phenotype.
Cytokine production in RLR-dependent macrophage polar-
ization. RLR-dependent macrophage immune effector function
was evaluated by cytokine and chemokine production (Supple-
mentary Fig. 8). WT cells secreted a range of cytokines and
chemokines of M1 including CXCL10 (IP-10), MIP-1α, MIP-1β,
and IL-6. The overall cytokine levels were similar across the
individual RLR knockouts while DKO cells were deficient in
cytokine production, revealing a broad impact of RLR signaling in
the expression of inflammatory (CXCL5; IL-6) and immune-
activating (IL-12) cytokines relevant to the M1 phenotype. These
results show that, as with the overall gene signature, both RIG-I
and MDA5 are required for inflammatory and immune-
regulatory cytokine production during WNV infection.
Macrophage polarization in vivo during WNV infection. To
determine how RLR signaling directs macrophage polarization
during WNV infection in vivo, we assessed macrophage
polarization phenotype during WNV infection. Flow cytometry
cell analysis to evaluate the activation/phosphorylation state of
STAT1 and STAT6, key transcription factors for M1 and M2,
respectively, revealed that RLR-deficient mice had dysregulated
macrophage polarization in vivo (Fig. 6a, gating strategy Sup-
plementary Fig. 9). Our analyses may include a small propor-
tion of non-macrophage myeloid cells, though, on average, 90+
% of the cells were also CD64+ and MerTK+24 (Supplementary
Fig. 10). DKO mice had a trend of increased absolute numbers
of CD11b+F4/80+ macrophages under mock infection condi-
tions. During WNV infection the number of M1 macrophages
in the peripheral tissues increased in WT mice but M1 mac-
rophage numbers failed to increase in DKO mice. Yet, M2
macrophages increased in DKO mice (Fig. 6b). The frequency
of M1 macrophages also was decreased in DKO mice compared
to WT mice, and they failed to significantly increase in response
to WNV infection (Fig. 6c). Overall the percentages of M2
macrophages in each tissue were similar between WT and DKO
despite the observed reductions in M1 cell percentage. Of note,
the DKO mice significantly increased the percentage of M1
Fig. 4 WT BMMs polarize to an M1 (inflammatory) phenotype in an RLR-dependent manner. a Radar plots of the WT and RIG-I/MDA5 DKO response
characterization. The DE genes from the WT samples were separated by time point and whether the gene was induced or suppressed, and then placed into
the six defined categories shown. The proportion of genes that were differentially expressed in the WT response out of the total possible genes in each
category was calculated. Those proportions are plotted on the spokes, where the higher proportions are plotted further from the center with the WT
response connected by black lines. The top radar plots are induced genes while the bottom radar plots are suppressed genes at 24 (left) and 48 (right)
hours. The red line overlay is the DKO DE gene proportions for each category. n= 3 (DKO), 4 (LGP2−/−, MDA5−/−, RIG-I WT, RIG-I−/−), or 5 (WT B6)
independent sequencing results. bWT and RIG-I/MDA5 DKO BMMs were infected with WNV at MOI 2.5 for 24 h and then analyzed for M1 (top) and M2
(bottom) gene expression. c Flow cytometry characterization of in vitro polarized BMMs. Plots show representative flow plots for polarized WT BMMs.
Graphs show the normalized MFI for each of the markers in WT and RIG-I/MDA5 DKO BMMs following polarization. d M1 gene expression was analyzed
in WT and RIG-I/MDA5 DKO BMMs following in vitro polarization. e, f Secreted nitrate (e) and arginase activity (f) were measured from in vitro polarized
WT and RIG-I/MDA5 BMMs. g M2 gene expression was analyzed in WT and RIG-I/MDA5 DKO BMMs following in vitro polarization. In panels b, e, f,
bars are means ± SEM. In panels c, d, g, bars are the mean fold change over the mock condition for each genotype and gene (ΔΔCT, normalized to Rrpl37)
± SEM. Combined data from n= 2 (b, c, f), 3 (d, g), or 4 (e) independent experiments. *p < 0.05, **p < 0.01 (two-tailed unpaired Holm-Sidak method;
modified t-tests). Source data are provided as a Source Data file
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macrophages in the brain albeit with reduced levels compared
to WT. We observed more infectious virus production from
brain and spleen tissue of DKO mice (Fig. 6d). When BMM
were treated with M1 or M2-polarizing stimuli ex vivo we
found that M1 macrophage polarization effectively controlled
WNV better than M2 or Mock polarized BMMs regardless of
genotype, as shown by FFU and WNV genomic copy number
PCR (Fig. 6e, f). These results reveal that the RLR signaling
through RIG-I and MDA5 contributes to macrophage polar-
ization in vivo and a component of macrophage differentiation
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to the M1 phenotype in peripheral tissues for the control of
WNV infection in both the spleen and brain.
ATF4 and SMAD4 may link the RLRs to macrophage polar-
ization. To assess the linkage of RLR signaling to downstream
macrophage transcriptional signatures and polarization pheno-
types, we conducted an unbiased bioinformatics analysis to pre-
dict upstream transcriptional regulators of the WNV-induced
transcriptome (Fig. 7a). This analysis identified two transcription
factors (TFs), ATF4 and SMAD4, whose target genes were highly
enriched in WT BMMs but were absent in DKO BMMs, indi-
cating that ATF4 and SMAD4 potentially operate as RLR-
response TFs. Both TFs are predicted to be inhibited in the WT
response but activated in the DKO response. Neither of these TFs
has been previously linked to antiviral responses. ATF4 is a
central responder to cellular stress, including inducing monocyte/
macrophage recruiting chemokines25,26 while SMAD4 acts in
transforming growth factor (TGF)-β signaling and BAFF induc-
tion in macrophages27,28. ATF4 and SMAD4 each associated with
suppression of target genes in the WT BMM response to WNV
while suppression is lost in the DKO BMM response to infection
(Fig. 7b, c, compare left and right panels, respectively). We found
that target genes of each TF included a variety of M1 and/or M2
genes whose expression was found to be differentially regulated in
WT and DKO cells. This computational analysis suggests that
RLR signaling might link to ATF4 and SMAD4 for macrophage
programming following virus sensing.
Discussion
Here we have defined the RLR-responsive transcriptome in pri-
mary BMM from WT and RLR-deficient mice, revealing that
RIG-I and MDA5 signaling programs macrophages to an M1
phenotype for immune protection against WNV. Macrophages
are targeted by WNV and are critical for immune protection
against virus infection16 and in neuroinvasion10. Signaling pro-
cesses direct macrophage function and polarization toward
inflammatory/M1 or anti-inflammatory-wound healing/M2 phe-
notypes15. We show that RLR signaling, by the combined actions
of RIG-I and MDA5, direct a predominant M1 phenotype while
suppressing the M2 phenotype within the protective response
against WNV infection. Our study reveals that RIG-I and MDA5
are essential during WNV infection serving as PRRs for virus
sensing and inducing innate immune defenses that control
infection. Our systems-based study identifies ATF4 and SMAD4
as RLR-sensitive downstream TFs potentially regulating macro-
phage polarizing gene expression.
Our direct comparison of each RLR in protection against WNV
infection shows that antiviral immune signaling ex vivo is con-
trolled by the combination of RIG-I and MDA5. The transcrip-
tional signature of macrophages programmed through RLR
signaling shows that this response integrates multiple gene
modules of broad function to polarize macrophages for immune
response regulation. RLR signaling was essential to produce
cytokines/chemokines of the M1 response. The catastrophic loss
of the WNV-induced transcriptome in the DKO cells demon-
strates that the RLRs are key mediators of the macrophage
immune response and immune regulation in general.
Each RLR contributes uniquely to defense against WNV
infection. RIG-I was essential for inducing innate immune genes
comprising the acute host response to infection while MDA5
linked closely with macrophage production of inflammatory and
immune-regulatory genes and cytokines. RIG-I and MDA5 in
their roles of PRRs of WNV likely function in series to recognize
distinct PAMPs produced during acute WNV infection. In this
sense, RIG-I is thought to mediate first recognition of WNV to
initiate RLR signaling, which is then amplified upon later by
distinct PAMP recognition by MDA55. Our results indicate that
this process of RLR signaling in series diversifies the host
response to include genes involved in immune regulation such as
Th1 and Th2 genes while driving robust IFN and ISG expression.
Confirmation of these observations in vivo with RLR-deficient
macrophages in an intact host are ongoing.
We identified non-ISG virus-regulated genes that are instead
regulated by RLR signaling. These virus-induced genes in mac-
rophages include modules that program the immune response
following macrophage polarization and include direct IRF target
genes, reflecting the role of IRFs as major downstream tran-
scription factors of RLR signaling1. While RIG-I signaling initi-
ates macrophage activation, MDA5 signaling expands the
macrophage response to cytokine/chemokine production. In the
absence of an RLR, RIG-I or MDA5 can partially compensate to
impart macrophage activation and M1 polarization but both
RLRs are required for immune protection against WNV. It is
important to note that splenic macrophages are essential for the
control of WNV infection and neuroinvasion in vivo11. Beyond
induction of gene expression, we show that RLR signaling directs
the suppression of specific gene expression in macrophages
during WNV infection. We found that suppressed genes were
typically linked to macrophage activation and innate immune
effector phenotypes related to differential M1/M2 polarization29.
Our data sets indicate that LGP2 imparts an amplification of
gene expression within modules of interferon signaling and cell
differentiation/activation relevant to M2 and Th1 suppression/
Th2 activation. LGP2 has been defined as a regulator of RLR
signaling30,31. Similar to studies showing multiple distinct roles
for LGP2, our data show that negative regulation is removed in
LGP2−/− macrophages but also reveals other possible roles for
LGP2 in governing immune polarization gene expression, sup-
porting LGP2 as an RLR signaling cofactor32,33 rather than an
RLR itself, but additional studies will be required to fully distin-
guish the role of LGP2 in modulating the anti-WNV response in
macrophages.
Our bioinformatics analysis identified ATF4 and SMAD4 as
potential regulators in innate immune responses to viruses. By
inhibiting these TFs, RIG-I and MDA5 may impart macrophage
Fig. 5 Unique RIG-I, MDA5, and LGP2 transcriptional responses following WNV infection. a Venn diagram showing the overlap in numbers of RLR-
dependent. Red numbers are induced genes while blue numbers are suppressed genes. b Heatmap showing the significantly enriched induced (top, in red)
and suppressed (bottom, in blue) GO terms across RIG-I, MDA5, and LGP2 deficient cells. Grey indicates that GO term was not significantly enriched in
the samples and are therefore dependent on the specific RLRs for gene module regulation. Each horizontal line represents a GO term while the columns are
the genotype of the samples. The color represents the adjusted p-value (co-expression) of the enrichment where a darker color indicates a smaller (more
significant) p-value. c Radar plots of the RIG-I, MDA5 and LGP2 deficient responses. Genes were categorized, and proportions calculated as in Fig. 4. Top
radar plots are the categorization of the genes that were present in each genotype’s response. Bottom radar plots are the categorization for the RLR-
dependent genes (genes altered in WT response, but unaltered in RLR-KO response). RIG-I is shown in yellow, MDA5 is shown in red, and LGP2 is shown
in blue. n= 3 (DKO), 4 (LGP2−/−, MDA5−/−, RIG-I WT, RIG-I−/−), or 5 (WT B6) independent infections, RNA preparations, and sequencing results.
Source data are provided as a Source Data file
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polarization and function. ATF4 is a known stress response factor
that regulates gene expression to recruit macrophages to sites of
inflammation25,26, but here BMMs with intact RLRs suppress the
ATF4 response, suggesting that a cell-level stress response is not
productive in controlling WNV. SMAD4 has previously been
reported to control BAFF production in macrophages27, which
contributes to downstream antibody responses through AID
expression in B cells34. Our data indicate that downregulation of
SMAD4 may be RLR-dependent and may help to polarize the
overall immune response towards an M1/Th1 cytotoxic response
as opposed to an M2/Th2 antibody-based response. These two
pathways may work in concert within the macrophage to mediate
macrophage and immune polarization. Macrophage polarization
has been directly linked to viral outcomes, and manipulation of
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macrophage polarization can effectively alter viral disease pro-
gression35. Mouse microglia take on proinflammatory/M1 mac-
rophage characteristics during WNV infection that protects
neighboring cells from cytotoxic effects36. Our study connects
these observations to peripheral macrophages and in vivo infec-
tion in which M1 polarization, potentially driven by RLR
recognition of WNV, confers control of viral replication and
neuroinvasion (Fig. 6). The generation of macrophage-specific
RLR knockout mice will shed insight on the specific contribution
of RLR programming in macrophages during WNV infection
in vivo in future studies.
While TLR3 and 7 are expressed in macrophages, loss of RIG-I
and MDA5 ablates transcriptional responses to WNV infection
though TLRs are still expressed and functional. TLRs play an
important role in WNV defense in vivo and in neurons37 but our
data show that in macrophages, the RLRs are the dominant
sensing receptors. TLR3 has previously been shown to direct a
response that facilitates neuroinvasion by WNV38, supporting
that RLR-based recognition leads to effective antiviral responses
against WNV while TLR-based recognition does not. These dis-
parate outcomes of TLR versus RLR immune protection have
implications for vaccine adjuvant and antiviral therapeutic stra-
tegies that target innate immune factors for immune enhance-
ment and flavivirus control. Targeting RLRs for antiviral actions
could provide a polarized innate immune response for the control
of WNV infection.
Our observations support a model where pathogen recognition
and signaling by RLRs during acute WNV infection leads per-
ipheral monocytes and tissue-resident macrophages into an M1
phenotype through parallel regulation of ATF4/SMAD4 with
canonical STAT signaling to mediate M1 gene induction and M2
gene suppression. The resulting M1 macrophages would then
directly restrict WNV replication and suppress virus spread.
Effector functions of M1 macrophages may then facilitate the
activation and polarization of the adaptive immune response to
promote viral clearance. This outcome would depend on rapid
signaling and sensing of WNV PAMPs wherein loss of RLRs
compromise this response and increase susceptibility to neu-
roinvasion. Robust M1 macrophage activation by RLRs is critical
for protection against WNV, and potentially for other
flaviviruses.
Methods
Experimental model and subject details. Mice: All animal procedures were
performed in compliance with all ethical regulations regarding animal-based
research and this study received ethical approval from the University of
Washington Institutional Animal Care and Use Committee. Mice (Mus musculus)
were housed at the University of Washington SPF animal facility in Allentown
filtered air cages with water bottles and no more than five mice of the same sex per
cage. The mice used in these studies were healthy sex-matched females and males
between 8–10 weeks in age that were naïve to any previous experimentation. The
C57Bl/6J (WT) mice were purchased from Jackson Laboratories. All other geno-
types used were bred in-house. MDA5−/−, and LGP2−/− have a 100% C57Bl/6J
background, while the RIG-I−/−, RIG-I+/+WT, and DKO all have a mixed C57Bl/
6J and 129 × 1/SvJ background (F3 backcross from 129 × 1/SvJ to C57Bl/6). At the
time of the experiments, mice weighed between 16.00–26.00 g.
The experimental groups (3–5 mice per group per experiment) were infected
with 100 pfu WNV-TX in the footpad under anesthesia while the control groups
were injected with an equal volume of PBS in the same procedure as the
experimental groups. This subcutaneous footpad injection has been used previously
to mimic the infection route of WNV through its mosquito vector39. Mice from
each genotype were randomly assigned to either the experimental or control groups
in equal numbers. Each mouse was monitored individually for clinical symptoms
and weight loss over 6 (immune polarization experiments) or 21 days (morbidity
and mortality experiments), euthanizing mice as they reached 20% initial weight
loss or severe clinical symptoms. The number of mice used was determined via
power calculation with an alpha of 0.05.
Spleens, brains, and IP lavage were collected from mice day six post-infection
for analysis. Half of each organ (spleen and brain) was lysed using the Percellys
lysis system and used for plaque forming unit (PFU) assay. Half of the spleens were
processed for flow cytometer by disruption using the GentleMacs system
(Miltenyi), then cells were stained as described below. Half of the brains were
mashed through a 0.7-um tissue sieve (Bellco) and submitted to a hypertonic
percoll gradient (1:10 10XPBS to Percoll [GE]) to remove excess myelin. Cells were
then stained for flow cytometry.
Primary mouse cells: Femurs from C57Bl/6, MDA5−/−, RIG-I+/+, RIG-I−/−,
LGP2−/−, and DKO mice (mixed male and female for each genotype) were
harvested via sterile post-mortem extraction and bone marrow was isolated. After
red blood cell lysis, the collected bone marrow was frozen and stored in liquid
nitrogen. Upon defrosting, bone marrow cells were plated in DMEM+ 10% FBS+
1X NEAA+ 1X L-glutamine+ 1X Na-pyruvate+ 1 mM HEPES+ 1X Gentamicin
(cDMEM-10) with 40 ng per mL murine MCSF for 7 days, replenishing the media
on day 3 and day 6 to differentiate the cells into macrophages (bone-marrow-
derived macrophages [BMMs]).
Method details. Virus: The WNV-TX02 infectious clone was isolated in the Gale
Laboratory18,40. Stocks were generated for this study by infecting Vero cells at an
MOI of 0.1 and harvesting filtered supernatant at day 5 post-infection.
Viral foci forming unit assays: Viral foci forming unit assay were performed on
Vero cells in 96-well plates. Cells were infected for 2 h with dilutions of cellular
supernatants. At that point, 125 uL of Methylcellulose medium was added to each
well. The cells were then incubated for an additional 22 h at which point, the cells
were fixed with 4% PFA in PBS. Plates were washed, and cells were stained with a
FITC-conjugated anti-WNV E protein antibody (1:500 diltuion; kindly provided by
Diamond Lab). After 2 h of staining, the cells were washed, and full wells were
imaged on the Incucyte (Essen). FFU were calculated for each sample based upon
the number of detected foci per well in triplicate wells.
Viral plaque forming unit assays: Viral plaque forming unit assays were
performed on Vero cells in 6-well plates. Cells were infected for 2 h with dilutions
of lysed organs in media. Then 2 mL of overlay (50% 1% agarose in water, 40% 2X
DMEM, 5% NaHCO3, 5% heat-inactivated FBS) was added to each well. The cells
were then incubated for an additional 70 h at which point 2 mL of developing
overlay (50% 1% agarose in water, 37% water, 10% 10X DPBS, 3% Neutral Red
solution [Sigma]) was added. The neutral red overlay was allowed to develop for
6–8 h and then visible plaques were counted. PFU per mg of the organ were
calculated for each sample based on the visible plaques per well in duplicate wells
and the mg of tissue added to each well.
Infection of cells: BMMs were prepared as described above, then lifted, counted
and plated at 1 × 106 cells per mL. Cells were allowed to adhere overnight and then
infected with WNV-TX infectious clone at a multiplicity of infection (MOI) of
Fig. 6 RIG-I and MDA5 are essential for macrophage polarization in vivo during WNV infection. WT or RIG-I/MDA5 DKO mice were infected with 100 pfu
of WNV for 6 days. Spleens, brains, and IP lavage were harvested and analyzed. a Flow cytometry gating strategy for identification of CD11b+
F4/80+ cells, M1, and M2 populations. Representative histograms for STAT1pY701 and STAT6pY641 shown on right from three infected spleen samples
and a representative mock from each genotype. b Absolute number of CD11b+ F4/80+ cells (left column), M1 (STAT1pY701+) cells (middle) and M2
(STAT6pY641+) cells (right column) from the IP lavage (top), spleen (center), or brain (bottom) from WT mice (blue) and RIG-I/MDA5 DKO (red).
c Frequency of CD11b+ F4/80+ cells (left column), M1 (STAT1pY701+) cells (middle) and M2 (STAT6pY641+) cells (right column) as measured by flow
cytometry from the IP lavage (top), spleen (center), or brain (bottom) from WT mice (blue) and RIG-I/MDA5 DKO (red). d PFU per mg of tissue for
spleens and brains from the mice assayed in previous panels. Each symbol represents a single organ from WT mice (blue) or RIG-I/MDA5 DKO mice
(red). The lines are the means ± SEM. n= 3 mice per group per genotype. e WT (blue) or RIG-I/MDA5 DKO (red) BMMs were in vitro polarized and
infected with WNV. FFU per mL of supernatant are shown. f RNA from in vitro polarized, WNV-infected WT (blue) or RIG-I/MDA5 DKO (red) BMMs was
assayed for genomic copies of WNV. For panels e, f, bars are means ± SEM. For panels b, c, e, f, data are combined from n= 3 independent experiments,
and lines are the means ± SEM with the following total mouse numbers: Mock WT n= 6; Mock DKO n= 2; WNV WT n= 11; WNV DKO n= 6. Stars
indicate statistical significance between the marked groups (Welch’s unpaired t-test). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Source data are
provided as a Source Data file
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2.5 for 2 h at which point the inoculum was removed and replaced with fresh
media. Cells were then incubated for 22 or 46 additional hours. Cells were then
harvested for RNA (Qiagen RNeasy Mini kit, 74106, as per manufacturer’s
instructions) or protein (described below) and the supernatants were harvested and
stored at −80 °C.
Macrophage polarization: BMMs were prepared as described above, then lifted,
counted, and plated at 1 × 106 cells per mL. Cells were allowed to adhere overnight
and then stimulated with recombinant murine IFNγ (50 ng per mL final
concentration; Peprotech) and LPS (100 ng per mL final concentration; B5
Invivogen) for M1 polarization, recombinant murine IL-4 (100 ng per mL final
concentration; Peprotech) and IL-13 (100 ng per mL final concentration;
Shenandoah) for M2 polarization, or PBS for Mock polarization for 24 h. RNA, cell
lysates for arginase activity (described below), and supernatants were harvested as
described above. For infection control experiments after 24 h of polarization, the
stimulating media was removed and infected as described above. After 22 h of
additional incubation, cells were harvested for RNA and supernatants.
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Fig. 7 ATF4 and SMAD4 are potential mediators of the RLR-based macrophage response to WNV. a Upstream regulator analysis predicted regulators
(Z-scores) are shown by heatmap where red shows predicted activation and blue shows predicted inhibition. This analysis was filtered to remove all
regulators that had the same directionality in WT and DKO data sets as well as any regulator that had a zero Z-score in either dataset (bottom).
b, c Network analysis of ATF4 target genes (b), SMAD4 target genes (c) and M1/M2 signature genes (both) in the WT response (left) and the DKO
response (right). Predicted upstream transcriptional regulators are noted as orange octagons with the remaining nodes in our network are labeled by gene
name. In the networks, shapes indicate gene category (circles—transcription factor target gene, octagon—regulator of interest, diamonds—M1 genes,
triangles—M2 genes, and squares—activators). The colors are the directionality of the gene in our dataset (red is induced, blue is suppressed, and white is
not changed compared to mock). n= 3 independent infections, RNA preparations, and sequencing results. Source data are provided as a Source Data file
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RNA sequencing: RNA from cells infected as above were subjected to RNAseq
(Expression Analysis, NC). The bioinformatics analysis of this data was performed
in conjunction with The Center for Innate Immunity and Immune Disease (CIIID)
Immune-informatics core group. The 48-hour DKO infection exhibited high
cytopathic effects and thus reduced RNA quality to the extent that this sample
point needed to be excluded from analysis.
RT-PCR: RNA from cells infected as above were reverse-transcribed into cDNA
(Bio-Rad iScript or Qiagen QuantiTect RT kit, 205313, as per manufacturer’s
instructions). cDNA was analyzed by RT-PCR using listed primers purchased from
Qiagen, SYBR Green master mix (QuantiFast SYBR Green PCR kit, 204057 or
ThermoFisher SYBR Green PCR Master Mix, 4309155) were used as per
manufacturer’s instructions. PCR reactions were run on a 384-well Viia7 (Applied
Biosystems) and analyzed using the ΔΔCT method.
WNV copy number RT-PCR: From cDNA generated as described above, WNV
genomic copies were amplified and detected using TaqMan reagents (Forward 5’
CCTGTGTGAGCTGACAAACTTAGT 3’; Reverse 5’
GCGTTTTAGCATATTGACAGCC 3’, Probe 5’ 6FAM CCT GGT TTC TTA GAC
ATC GAG ATC TTC GTG C TAMRA 3’, and TaqMan Virus Master Mix Life
Technologies #444432) then compared to a standard curve.
Western blots: Protein was isolated from infected cells by lysing the cells in a
modified RIPA buffer (Tris-HCl 50 mM, 1% NP-40, 0.25% Na-deoxycholate, NaCl
150 mM, EDTA 1 mM pH 7.4) with protease and phosphatase inhibitors
(Calbiochem 80501-130, Okadaic Acid [Fisher 49-560-4100UG], EDTA [100 uM],
PMSF [200 uM] Sigma P8340). Cell lysates were agitated for a minimum of 30 min
at 4 °C and then cleared via centrifugation. Cleared lysates were quantified by BCA
assay (Thermo Scientific Fisher, PI-23221, and PI- 23224). Cell lysates were then
separated by SDS-PAGE and transferred to a nitrocellulose membrane using a wet
transfer system. Membranes were blocked with PBS- or TBS-based Odyssey
Blocking buffer (Li-COR), washed, and proteins were analyzed by immunoblotting
with standard methods using antibodies specific to listed proteins. Secondary
antibodies conjugated to either AlexaFluor 680 or AlexaFluor 790 (1:10,000
dilution) were obtained from Jackson ImmunoResearch and Li-COR.
Immunoreactive bands were detected on the Li-COR Odyssey Scanner. When
required, blots were stripped with 0.2 M NaOH for five minutes.
Flow cytometry: Cells were prepared and, as needed, infected as described
above. Cells were gently washed with DPBS (Ca2+ and Mg2+ free) and stained with
V450 or V506 Fixable Live/Dead stain (eBioscience). Cells were then washed in
FACS Wash (PBS with 0.016% sodium azide, 0.6% BSA), resuspended in FACS
Wash containing fluorescently labeled antibodies, and incubated at 4 °C for 30 min.
Cells were then washed twice in FACS Wash and resuspended in Brilliant Violet
fluorescently labeled antibodies diluted in Brilliant Violet Staining Buffer (BD
Biosciences) and incubated for 30 min at 4 °C. Cells were then washed twice in
FACS wash and resuspended in 4% PFA in PBS for 20 min. Cells were then
permeabilized with BD Perm/Wash Buffer (BD Biosciences) for 1 h 4 °C then
pelleted and resuspended with intracellular antibodies in BD Perm/Wash Buffer for
30 min. After a final wash, cells were acquired on an LSRII flow cytometer (BD
Biosciences). Flow cytometry data were analyzed using the FlowJo Software
(TreeStar).
Table 1 Reagents table
Reagent
Type
Description Source Identifier
Antibody Goat polyclonal anti-West Nile Virus NS3 (1:1000 dilution) R&D systems Cat#BAF2907; RRID: AB_2215927
Antibody Rabbit monoclonal anti-RIG-I (D14G6) (1:1000 dilution) Cell Signaling Technologies Cat#3743S; RRID: AB_2269233
Antibody Rabbit polyclonal anti-MDA5 (1:1000 dilution) ProSci Cat#4037; RRID: AB_735447
Antibody Rabbit polyclonal anti-LGP2 (1:1000 dilution) Proteintech Group Cat#11355-1-AP; RRID: AB_2092319
Antibody Goat polyclonal anti-Actin (I-19) (1:1000 dilution) Santa Cruz Biotechnology, Inc Cat#sc-1616; RRID: AB_630836
Antibody Rat anti-CD283 (TLR3) PE (1:100 dilution) Biolegend Cat#141903; lot#B183765; RRID: AB_10895749
Antibody Mouse anti-CD287 (TLR7) PE (clone: A94B10) (1:100
dilution)
BD Biosciences Cat#565557 lot#5117683
Antibody Rat anti-CD11b PE-Cy7 (clone: M1/70) (1:160 dilution) Thermo Fisher Scientific Cat#25-01112-82; lot#E07514-1633; RRID:
AB_469588
Antibody Rat anti-MHCII AlexaFluor700 (clone: M5/114.15.2)
(3:1000 dilution)
Thermo Fisher Scientific Cat#56-5321-82; lot#E09021-1631; RRID:
AB_494009
Antibody Humanized E16 mouse anti-WNV E (1:500 dilution) Michael Diamond’s Lab47 N/A
Antibody Rat anti-CD19 APC-Cy7 (clone: 6D5) (1:200 dilution) Biolegend Cat#115530; lot#B228154;RRID: AB_830707
Antibody Rat anti-CD3 redFluor710 (Clone: 17A2) (1:40 dilution) Tonbo Biosciences Cat#80-0032-U100; lot# C003202516803; RRID:
AB_2621971
Antibody Rat anti-F4/80 eFluor450 (clone: BM8) (1:40 dilution) Thermo Fisher Scientific Cat#48-4801-80 lot#4278803; RRID:
AB_1548756
Antibody Mouse anti-phospho-STAT1 (pY701) AlexaFluor647 (clone:
4a) (1:10 dilution)
BD Biosciences Cat#612597; lot# 7080509; RRID: AB_399880
Antibody Mouse anti-phosoho-STAT6 (pY641) PE-eFluor610 (Clone:
CHI2S4N) (1:20 dilution)
Thermo Fisher Scientific Cat#61-9013-41; lot# 4329183; RRID: AB_2574673
Antibody Arm. Hamster anti-CD11c PerCP-Cy5.5 (N418) (1:80
dilution)
Thermo Fisher Scientific Cat # 45-0114-80; Lot#4299461
Antibody Rat anti-MerTK SuperBright 600 (DS5MMER) (1:20
dilution)
Thermo Fisher Scientific Cat#63-5751-82; lot#4345210
Antibody Rat anti-MerTK SuperBright 702 (DS5MMER) (1:20
dilution)
Thermo Fisher Scientific Cat#67-5751-82; lot#1942740
Antibody Rat anti-CD206 BV605 (C068C2) (1:20 dilution) Biolegend Cat#141721; lot#B248321
Antibody Mouse anti-CD64 BV786 (X54-5/7.1) (1:40 dilution) BD Biosciences Cat#741024; lot#8053613
Antibody Rat anti-CD14 PE (Sa2-8) (1:40 dilution) Thermo Fisher Scientific Cat#12-0141-82; lot#4344716
Antibody Rat anti-CD45 SuperBright 645 (30-F11) (1:40 dilution) Thermo Fisher Scientific Cat#64-0451-82; lot#4339223
Mouse Mouse: Wild Type B6: C57Bl/6J The Jackson Laboratory JAX: 000664
Mouse Mouse: RIG-I WT: B6.129x1/SvJ.RIG-I+/+ Akira Lab;48 N/A
Mouse Mouse: RIG-I-/-:B6.129x1/SvJ.RIG-I-/- Akira Lab;48 N/A
Mouse Mouse: MDA5-/-: B6.MDA5-/- Colonna Lab;5,49,50 N/A
Mouse Mouse: DKO: B6.129x1/SvJ Gale Lab5 N/A
Mouse Mouse: LGP2-/-: B6.LGP2-/- Gale Lab17 N/A
Primer Mm 18S rRNA primer Qiagen QT02448075
Primer Mm IFNB primer Qiagen QT00249662
Primer Mm Rrpl37 primer Qiagen QT00112266
Primer Mm IL-10 primer Qiagen QT00106169
Primer Mm IL-1b primer Qiagen QT01048355
Primer Mm IL-6 primer Qiagen QT00098875
Primer Mm NOS2 primer Qiagen QT00100275
Primer Mm TNFa primer Qiagen QT00104006
Primer Mm CXCL1 primer Qiagen QT00115647
Primer Mm Pparg primer Qiagen QT00100296
Primer Mm Chil3 primer Qiagen QT00108829
Primer Mm Arg1 primer Qiagen QT00134288
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11250-5 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3649 | https://doi.org/10.1038/s41467-019-11250-5 |www.nature.com/naturecommunications 13
Nitrate concentration analysis: Cellular supernatants were analyzed for
concentration of nitrate using a Griess Assay kit (Promega) as per the
manufacturer’s instructions.
Arginase activity analysis: BMMs polarized as described above were lysed and
analyzed for arginase activity using the QuantiChrom Arginase Assay kit (BioAssay
Systems) as per the manufacturer’s instructions.
For antibodies, mouse lines, and primers, see Table 1.
Software availability. All software tools (R/Bioconductor, star, cut adapt, ht-seq)
are free and open source.
Quantification and statistical analysis. RNAseq data processing and analysis:
Raw RNAseq data (FASTQs) were checked for quality (FastQC version 0.11.3),
then adapters and rRNA were digitally removed (cut adapt, version 1.8.3 and
Bowtie2 version 2.2.5). Roughly thirty million raw reads were mapped against the
WNV viral and the mm10 (mouse) reference genomes separatel41. mm10 genome
content was obtained from Illumina’s igenomes site (https://support.illumina.com/
sequencing/sequencing_software/igenome.html). Host alignments were performed
using STAR (2.4.2) against UCSC MM10 and then converted into gene counts with
ht-seq (0.6.0). Viral alignments were performed using Bowtie2 version 2.2.5 against
WNV TX 2002-HC DQ17663740. Gene counts were then loaded in the R statistical
programming language (version 3.2.0) and filtered by a mean of ten or greater
across all samples.
A mm10 gene count matrix was then normalized using the voom package in R/
Bioconductor. Differential expression was performed using the limma package in
R/Bioconductor. Additional graphics packages were utilized for the visualization of
numbers of differentially expressed genes (ggplot2), radial plots (plotrix), and
heatmaps (gplots).
Co-expression heatmap: Co-expression was performed only on genes that were
determined to be statistically significant from the differential expression analysis
(threshold: log2 fold change ≥ | 2 | and FDR ≤ 0.05) in at least one comparison.
Correlations (ward clustering and Euclidean distance) were run on the union of
log2FC values using the WGCNA and heatmap.2 Bioconductor packages in R42–44.
Matrisome heatmap: The global list of differentially expressed genes were
compared against known genes associated with the Matrisome20 . We then plotted
those Matrisome-associated DE genes in a heatmap.
Please see the R markdown documents for additional information [http://stone.
galelab.org].
IPA pathway and regulator analysis. A list of statistically significant, differen-
tially expressed genes (threshold of significance of a > | 2 |-fold change over mock
with a Benjamini-Hochberg-adjusted p-value ≤ 0.05) were uploaded into Ingenuity
Pathway Analysis (IPA) for core analysis to identify enrichment of biological
pathways. IPA produced a list of known biological functions with an enrichment
score (−log p-value) determining how significant those genes are to each function
and an activation z-score that indicates the proposed activation of that pathway
(activated or inhibited). The z-score is based on knowledge of expression changes
(and functions) in the Ingenuity knowledge base45.
Venn diagrams: The total DE gene list was filtered by specific functional groups
(Th1, Innate, ISG, and M1) and then these lists were compared using venny an
online Venn diagram tool46.
Additional statistics: Additional statistics were performed using GraphPad
Prism statistical package (versions 7.03 and 7.04).
Figure 1a: Survival Curve comparisons were Log-rank (Mantel-Cox) tests
between the WT and RLR-KO survival curves. WT vs. RIG-I−/− p= 0.0478; WT
vs. MDA5−/− p= 0.0018; WT vs. MAVS−/− p < 0.0001 Chi-square= 53.12; WT
vs. RIG-I/MDA5 DKO p < 0.0001 Chi-square= 51.85; WT vs. LGP2−/− p < 0.0001
Chi-square= 21.72. figure 1d: FFU comparisons were Ordinary one-way ANOVA
performed for each time point with Holm-Sidak’s multiple-comparisons post-test
(two-tailed; 24h t= 3.298, DF= 23; 48h t= 3.475, DF= 42).
Figure 4b: Comparisons were two-tailed unpaired Holm-Sidak method with
alpha= 0.5 DF= 6 (modified t-tests, p-values reported) IL-6 p= 0.003183 t= 4.742;
NOS2 p= 0.11348 t= 2.710; TNFa p= 0.021581 t= 3.083; CXCL1 p= 0.124645
Table 2 Statistical details for Fig. 6c WT vs RIG-I/MDA5
DKO: counts percentages
Organ Graph Cond. P-value T-value DF
IP CD11b+ Mock 0.0043 4.955 5
IP CD11b+ WNV 0.158 1.511 11
IP M1 Mock 0.607 0.5521 4
IP M1 WNV 0.080 1.952 10
IP M2 Mock 0.659 0.4796 4
IP M2 WNV 0.025 2.61 11
Spleen CD11b+ Mock 0.063 2.376 5
Spleen CD11b+ WNV 0.396 0.8739 15
Spleen M1 Mock 0.128 1.813 5
Spleen M1 WNV 0.002 4.103 11
Spleen M2 Mock 0.015 3.592 5
Spleen M2 WNV 0.729 0.354 12
Brain CD11b+ Mock <0.001 48.23 6
Brain CD11b+ WNV 0.172 1.56 6
Brain M1 Mock 0.083 2.134 5
Brain M1 WNV 0.0240 2.51 15
Brain M2 Mock 0.0158 3.33 6
Brain M2 WNV 0.0095 2.974 15
IP CD11b+ Mock 0.136 1.855 4
IP CD11b+ WNV 0.038 2.297 14
IP M1 Mock 0.002 7.363 4
IP M1 WNV 0.008 3.127 13
IP M2 Mock 0.041 2.962 4
IP M2 WNV 0.870 0.1715 6
Spleen CD11b+ Mock 0.028 3.058 5
Spleen CD11b+ WNV 0.282 0.1.117 14
Spleen M1 Mock 0.014 3.672 5
Spleen M1 WNV 0.030 2.393 15
Spleen M2 Mock 0.012 3.83 5
Spleen M2 WNV 0.619 0.5205 7
Brain CD11b+ Mock 0.213 1.513 4
Brain CD11b+ WNV 0.037 2.391 10
Brain M1 Mock 0.026 3.136 5
Brain M1 WNV 0.616 0.515 12
Brain M2 Mock 0.029 3.925 3
Brain M2 WNV 0.874 0.1639 7
Table 3 Statistical details for Fig. 6c: Mock vs. WNV (within
genotype) counts percentages
Organ Graph Geno. P-value T-value DF
IP CD11b+ WT 0.119 1.67 13
IP CD11b+ DKO 0.170 3.344 1
IP M1 WT 0.134 1.61 12
IP M1 DKO 0.405 1.277 2
IP M2 WT 0.019 2.761 11
IP M2 DKO 0.842 0.2134 4
Spleen CD11b+ WT 0.182 1.417 12
Spleen CD11b+ DKO 0.610 0.543 5
Spleen M1 WT 0.877 0.1601 7
Spleen M1 DKO 0.530 0.7042 3
Spleen M2 WT 0.003 3.462 15
Spleen M2 DKO 0.002 5.587 5
Brain CD11b+ WT 0.205 1.353 10
Brain CD11b+ DKO 0.500 0.7271 5
Brain M1 WT 0.122 1.797 6
Brain M1 DKO 0.131 1.807 5
Brain M2 WT 0.178 1.416 15
Brain M2 DKO 0.105 1.975 5
IP CD11b+ WT 0.808 0.258 12
IP CD11b+ DKO 0.003 5.82 5
IP M1 WT 0.158 1.503 13
IP M1 DKO 0.063 2.518 4
IP M2 WT 0.046 2.19 14
IP M2 DKO 0.155 1.175 4
Spleen CD11b+ WT 0.961 0.0502 9
Spleen CD11b+ DKO <0.001 7.613 5
Spleen M1 WT 0.141 1.661 7
Spleen M1 DKO 0.142 1.712 6
Spleen M2 WT 0.487 0.7154 13
Spleen M2 DKO 0.046 2.647 5
Brain CD11b+ WT 0.064 2.165 8
Brain CD11b+ DKO 0.215 1.532 3
Brain M1 WT 0.363 0.9534 10
Brain M1 DKO <0.001 8 5
Brain M2 WT 0.247 1.238 9
Brain M2 DKO 0.065 2.361 5
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t= 1.784; PPARg p= 0.296637 t= 1.143; Chil3 p= 0.991537 t= 0.01106; Arg1 p=
0.242478 t= 1.296. Figure 4c: MFIs were normalized to Mock polarized MFI values
(arbitrarily set to 100) and comparisons were two-tailed unpaired Holm-Sidak
method with alpha= 0.5 DF= 2 (modified t-tests, adjusted p-values reported).
MerTK – M1 p= 0.8267 t= 0.4631, M2 p= 0.8267 t= 0.6476; CD64 - M1 p=
0.3676 t= 1.855, M2 p= 0.4142 t= 1.022; CD14 - M1 p= 0.0307 t= 7.943, M2 p=
0.4361 t= 0.9656; CD11c - M1 p= 0.7118 t= 0.9, M2 p= 0.7118 t= 0.4311; CD206
- M1 p= 0.5029 t= 0.8102, M2 p= 0.4357 t= 1.61. Figure 4d, g: Comparisons were
two-tailed unpaired Holm-Sidak method with alpha= 0.5 DF= 16 (modified t-tests,
adjusted p-values reported) IL-10 p= 0.9229 t= 0.5117; IL-1b p= 0.9229 t= 0.7112;
IL-6 p= 0.1028 t= 2.638; NOS2 p= 0.9229 t= 0.2915; TNFa p= 0.9229 t= 0.7349;
CXCL1 p= 0.7717 t= 1.179; t= 1.092; PPARg p= 0.6401 t= 0.4766; Chil3 p=
0.3462 t= 1.587; Arg1 p= 0.2594 t= 1.924. Figure 4e: Comparisons were two-tailed
unpaired Holm-Sidak method with alpha= 0.5 (modified t-tests, adjusted p-values
reported) M1 p= 0.1872 t= 1.709 DF=28; Mock p= 0.8232 t= 0.2262 DF=22.
Figure 4f: Comparisons were two-tailed unpaired Holm-Sidak method with alpha=
0.5 DF= 4 (modified t-tests, adjusted p-values reported) M2 p= 0.6322 t= 0.9552;
Mock p= 0.7538 t= 0.3359.
Figure 6b, c: percentage and count comparisons were two-tailed unpaired
Welch’s t-test between the genotypes for each organ and infection condition
(Tables 2, 3).
Figure 6d: PFU comparisons were one tailed t-tests between genotypes for each
organ. Spleen p= 0.2309 t= 1.702 DF= 2; Brain p= 0.0052 t= 13.88 DF=2.
Figure 6e Comparisons were two-tailed unpaired Holm-Sidak method with alpha
= 0.5 (modified t-tests, adjusted p-values reported) WT –DF= 21 M1 vs M2 p=
0.007 q= 4.833, M1 vs Mock p= 0.7874 q= 0.937, M2 vs Mock p= 0.0306 q=
3.896; RIG-I/MDA5 DKO DF= 36 M1 vs M2 p= 0.0003 q= 6.252, M1 vs Mock
p= 0.9636 q= 0.3668, M1 vs M2 p= 0.0005 q= 5.885. Figure 6f: Comparisons
were unpaired two-tailed t-tests. WT –M1 vs Mock p= 0.017 t= 2.744 DF=13,
M1 vs M2 p= 0.225 t= 1.255 DF=19, M2 vs Mock p= 0.9288 t= 0.0907 DF=16;
RIG-I/MDA5 DKO M1 vs Mock p= 0.037 t= 2.371 DF=11, M1 vs M2 p= 0.004
t= 3.67 DF=11, M2 vs Mock p= 0.008 t= 3.165 DF=12; WT vs RIG-I/MDA5
DKO – Mock p= 0.3369 t= 0,9901 DF=16, M1 p= 0.3536 t= 0.9509 DF=19, M2
p= 0.0021 t= 3.489 DF=22.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Sequencing data are in Gene Expression Omnibus (GEO) under accession GSE104817.
Data underlying Figs. 1A, B, D, 3D, 4B–G, 5B, 6B, C, E, F, 7A and Supp Figs. 1, 2A, 7E,
8A, 8B, and 10B are provided as Source Data files. All other data are available from the
corresponding author upon reasonable requests.
Code availability
R markdown data reports were generated for data analysis and figure reproducibility.
They can be found here: [http://stone.galelab.org/]
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